UNSPSC 51352426: Estradiol/norethindrone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS900. This VA Drug Class (HS900) classifies this compound as belonging to the group HORMONES/SYNTHETICS/MODIFIERS, OTHER.

UNSPSC 51352426 Estradiol/norethindrone, a Commodity code, addresses the procurement of combination hormone replacement therapy medications used in state and local public health systems, particularly within Medicaid programs, correctional healthcare, and public hospital pharmacy operations. State and local governments purchase this pharmaceutical product through their health agencies, pharmacy benefit managers, and institutional healthcare procurement systems to supply clinics, detention facilities, and hospital pharmacies serving eligible populations covered under state health plans. The combination estradiol and norethindrone formulation is a standard oral contraceptive and hormone therapy option stocked in public health inventories and dispensed through primary care and women's health programs.

The source provided contains no recent state or local contract opportunities solicited under this code. Without posted RFPs, RFQs, IFBs, or ITBs referencing UNSPSC 51352426, geographic concentration, issuing-body patterns, and current market activity cannot be characterized from real procurement data. Pharmaceutical commodities at this specificity typically flow through existing state contracts, group purchasing organizations, and standing agreements rather than individual competitive solicitations; however, absence of recent public notices makes assessment of current procurement volume and jurisdictional activity impossible.